USD 23.325
| ticker | 1 day return % | 1 week return % | 1 month return % | 3 months return % | 6 months return % | 1 year return % | 3 years return % | 5 years return % | 10 years return % | maximum return % |
|---|---|---|---|---|---|---|---|---|---|---|
| PGNY | -1.1 | 6.5 | 38.0 | 49.1 | -19.6 | -39.4 | -42.4 | -23.5 | 46.3 | 46.3 |
| S&P 500 | -0.5 | -1.3 | 1.2 | 3.5 | 10.5 | 22.6 | 33.7 | 84.5 | 198.8 | 34098.9 |
Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline
Feel free to experiment with these tools to enhance your technical analysis. Remember, any drawings you make are temporary and will be lost upon refreshing the page unless saved as an image using the 'Camera' icon.
Get instant AI-powered professional insights on prices:
💡Generate AI Technical Analysis ReportA Multi-Interval Candlestick Chart displays the price movements of an asset over different time intervals. Each candlestick represents the open, high, low, and close prices for a specific interval. The chart can be used to identify trends and patterns in price movements.
| Attribute | Value |
|---|---|
| symbol | PGNY |
| name | Progyny, Inc. |
| price | 23.325 |
| changes percentage | -1.1234 |
| change | -0.265 |
| day low | 23.22 |
| day high | 23.71 |
| year high | 42.08 |
| year low | 13.39 |
| market cap | 1986200723 |
| price avg 50 | 16.7586 |
| price avg 200 | 22.42205 |
| exchange | NASDAQ |
| volume | 857406 |
| avg volume | 1827071 |
| open | 23.39 |
| previous close | 23.59 |
| eps | 0.6 |
| pe | 38.88 |
| earnings announcement | 2025-02-25T10:59:00.000+0000 |
| shares outstanding | 85153300 |
| timestamp | 2025-01-29 20:45:55 |
We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0001551306 | |||
| revenue | 1088598000 | 786913000 | 38.34 |
| gross profit | 238799000 | 167325000 | 42.72 |
| gross profit ratio | 0.22 | 0.21 | 3.16 |
| research and development expenses | 0 | 0 | NaN |
| operating expenses | 176615000 | 143984000 | 22.66 |
| interest income | 0 | 814000 | -100.00 |
| interest expense | 0 | 814000 | -100.00 |
| ebitda | 64465000 | 24942000 | 158.46 |
| ebitdaratio | 0.06 | 0.03 | 86.83 |
| operating income | 62184000 | 23341000 | 166.42 |
| operating income ratio | 0.06 | 0.03 | 92.58 |
| net income | 62037000 | 30358000 | 104.35 |
| net income ratio | 0.06 | 0.04 | 47.72 |
| eps | 0.65 | 0.33 | 96.97 |
Revenue Growth: revenue decreased to 1,089 million in 2023 from 787 million in 2022 representing a change of 38.34%. This indicates a sales shrinking, which is a negative sign for the company.
Operating Expenses: Operating Expenses increased to 177 million in 2023 from 144 million in 2022 representing a change of 22.66%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.
Gross Profit: Gross Profit increased to 239 million in 2023 from 167 million in 2022 representing a change of 42.72%. This indicates a sales profitability growth, which is a positive sign for the company.
EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 64 million in 2023 from 25 million in 2022 representing a change of 158.46%. The increase in EBITDA indicates improved operational efficiency and profitability.
Operating Income: Operating income increased to 62 million in 2023 from 23 million in 2022 representing a change of 166.42%. The increase in operating income indicates better operational performance and increased profitability.
Net Income: Net income increased to 62 million in 2023 from 30 million in 2022 representing a change of 104.35%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.
Earnings per Share (EPS): EPS increased to 0.65 in 2023 from 0.65 in 2022 representing a change of 96.97%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0001551306 | |||
| revenue | 286625000 | 304087000 | -5.74 |
| gross profit | 59244000 | 68281000 | -13.24 |
| gross profit ratio | 0.21 | 0.22 | -7.95 |
| research and development expenses | 0 | 0 | NaN |
| operating expenses | 46786000 | 47594000 | -1.70 |
| interest income | 5504000 | 816000 | 574.51 |
| interest expense | 0 | 0 | NaN |
| ebitda | 12458000 | 21441000 | -41.90 |
| ebitdaratio | 0.04 | 0.07 | -38.36 |
| operating income | 12458000 | 20687000 | -39.78 |
| operating income ratio | 0.04 | 0.07 | -36.11 |
| net income | 10421000 | 16485000 | -36.78 |
| net income ratio | 0.04 | 0.05 | -32.93 |
| eps | 0.12 | 0.18 | -33.33 |
Revenue Growth: revenue decreased to 287 million in 2024Q3 from 304 million in 2024Q2 representing a change of -5.74%. This indicates a sales shrinking, which is a negative sign for the company.
Gross Profit: Gross Profit decreased to 59 million in 2024Q3 from 68 million in 2024Q2 representing a change of -13.24%. This indicates a sales profitability decline, which is a negative sign for the company.
EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 12 million in 2024Q3 from 21 million in 2024Q2 representing a change of -41.9%. The decrease in EBITDA indicates declined operational efficiency and profitability.
Operating Income: Operating income decreased to 12 million in 2024Q3 from 21 million in 2024Q2 representing a change of -39.78%. The decrease in operating income indicates worse operational performance and decreased profitability.
Net Income: Net income decreased to 10 million in 2024Q3 from 16 million in 2024Q2 representing a change of -36.78%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.
Earnings per Share (EPS): EPS increased to 0.12 in 2024Q3 from 0.12 in 2024Q2 representing a change of -33.33%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.
Operating Expenses: Operating Expenses decreased to 47 million in 2024Q3 from 48 million in 2024Q2 representing a change of -1.7%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0001551306 | |||
| total assets | 756620000 | 542986000 | 39.34 |
| total liabilities | 203191000 | 166018000 | 22.39 |
| total equity | 553429000 | 376968000 | 46.81 |
| cash and cash equivalents | 97296000 | 120078000 | -18.97 |
| short term investments | 273791000 | 69222000 | 295.53 |
| long term investments | 0 | 0 | NaN |
| total current assets | 640407000 | 433856000 | 47.61 |
| total non current assets | 116213000 | 109130000 | 6.49 |
| total current liabilities | 185950000 | 159536000 | 16.56 |
| total non current liabilities | 17241000 | 6482000 | 165.98 |
| common stock | 9000 | 9000 | 0.00 |
| retained earnings | 89971000 | 27934000 | 222.08 |
| total debt | 19390000 | 7713000 | 151.39 |
Total Assets: Total Assets increased to 757 million in 2023 from 543 million in 2022 representing a change of 39.34%. Suggesting a growth in asset holdings.
Total Equity: Total Equity increased to 553 million in 2023 from 377 million in 2022 representing a change of 46.81%. This indicates an increase in shareholders' equity.
Short Term Investments: Short Term Investments increased to 274 million in 2023 from 69 million in 2022 representing a change of 295.53%. This indicates an increase in short-term investment holdings.
Total Current Assets: Total Current Assets increased to 640 million in 2023 from 434 million in 2022 representing a change of 47.61%. This indicates a better liquidity position.
Retained Earnings: Retained Earnings increased to 90 million in 2023 from 28 million in 2022 representing a change of 222.08%. This indicates an accumulated profits.
Total Liabilities: Total Liabilities increased to 203 million in 2023 from 166 million in 2022 representing a change of 22.39%. This indicates an increase in overall liabilities.
Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 97 million in 2023 from 120 million in 2022 representing a change of -18.97%. This indicates a decrease in available liquid assets.
Total Current Liabilities: Total Current Liabilities increased to 186 million in 2023 from 160 million in 2022 representing a change of 16.56%. This indicates a higher short-term debt burden.
Total Debt: Total Debt increased to 19 million in 2023 from 8 million in 2022 representing a change of 151.39%. This indicates an increase in overall debt burden.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0001551306 | |||
| total assets | 659972000 | 698632000 | -5.53 |
| total liabilities | 225096000 | 242439000 | -7.15 |
| total equity | 434876000 | 456193000 | -4.67 |
| cash and cash equivalents | 91480000 | 94960000 | -3.66 |
| short term investments | 144240000 | 167228000 | -13.75 |
| long term investments | 0 | 0 | NaN |
| total current assets | 546302000 | 582243000 | -6.17 |
| total non current assets | 113670000 | 116389000 | -2.34 |
| total current liabilities | 208471000 | 225375000 | -7.50 |
| total non current liabilities | 16625000 | 17064000 | -2.57 |
| common stock | 9000 | 9000 | 0.00 |
| retained earnings | 133775000 | 123354000 | 8.45 |
| total debt | 16625000 | 19866000 | -16.31 |
Total Assets: Total Assets decreased to 660 million in 2024Q3 from 699 million in 2024Q2 representing a change of -5.53%. Suggesting a decrease in asset holdings.
Total Equity: Total Equity decreased to 435 million in 2024Q3 from 456 million in 2024Q2 representing a change of -4.67%. This indicates a decrease in shareholders' equity.
Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 91 million in 2024Q3 from 95 million in 2024Q2 representing a change of -3.66%. This indicates a decrease in available liquid assets.
Short Term Investments: Short Term Investments decreased to 144 million in 2024Q3 from 167 million in 2024Q2 representing a change of -13.75%. This indicates a decrease in short-term investment holdings.
Total Current Assets: Total Current Assets decreased to 546 million in 2024Q3 from 582 million in 2024Q2 representing a change of -6.17%. This indicates a worsen liquidity position.
Total Liabilities: Total Liabilities decreased to 225 million in 2024Q3 from 242 million in 2024Q2 representing a change of -7.15%. This indicates a decrease in overall liabilities.
Total Current Liabilities: Total Current Liabilities decreased to 208 million in 2024Q3 from 225 million in 2024Q2 representing a change of -7.5%. This indicates a lower short-term debt burden.
Retained Earnings: Retained Earnings increased to 134 million in 2024Q3 from 123 million in 2024Q2 representing a change of 8.45%. This indicates an accumulated profits.
Total Debt: Total Debt decreased to 17 million in 2024Q3 from 20 million in 2024Q2 representing a change of -16.31%. This indicates a reduction in overall debt burden.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0001551306 | |||
| net change in cash | -22782000 | 28665000 | -179.48 |
| operating cash flow | 188814000 | 80395000 | 134.86 |
| free cash flow | 185170000 | 77154000 | 140.00 |
| capital expenditure | -3644000 | -3241000 | -12.43 |
| depreciation and amortization | 2281000 | 1601000 | 42.47 |
| deferred income tax | 3745000 | -6615000 | 156.61 |
| stock based compensation | 122611000 | 100748000 | 21.70 |
| accounts payables | 16235000 | 47689000 | -65.96 |
| inventory | -12569000 | 0 | NaN |
| acquisitions net | 0 | 40625000 | -100.00 |
| investments in property plant and equipment | -3644000 | -3241000 | -12.43 |
| net cash used for investing activites | -200525000 | -43866000 | -357.13 |
| debt repayment | 0 | 0 | NaN |
| common stock issued | 6128000 | 3073000 | 99.41 |
| common stock repurchased | -17200000 | -12089000 | -42.28 |
| dividends paid | 0 | 0 | NaN |
| net cash used provided by financing activities | -11072000 | -7864000 | -40.79 |
| cash at end of period | 97296000 | 120078000 | -18.97 |
| accounts receivables | -21738000 | -119304000 | 81.78 |
| cash at beginning of period | 120078000 | 91413000 | 31.36 |
Net Change in Cash: Net Change in Cash decreased to -23 million in 2023 from 29 million in 2022 representing a change of -179.48%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.
Deferred Income Tax: Deferred Income Tax increased to 4 million in 2023 from -7 million in 2022 representing a change of 156.61%. This indicates that the company's tax liability for future periods has increased.
Stock-Based Compensation: Stock-Based Compensation increased to 123 million in 2023 from 101 million in 2022 representing a change of 21.7%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.
Accounts Receivables: Accounts Receivables increased to -22 in 2023 from -119 million in 2022 representing a change of 81.78%. This suggests that the company is less capable of collecting payments from its customers.
Operating Cash Flow: Operating Cash Flow increased to 189 million in 2023 from 80 million in 2022 representing a change of 134.86%. This indicates that the company generated more cash from its core business operations.
Free Cash Flow: Free Cash Flow increased to 185 million in 2023 from 77 million in 2022 representing a change of 140.0%. This indicates an increase in cash generated after accounting for capital expenditures.
Capital Expenditure: Capital Expenditure decreased to -4 million in 2023 from -3 million in 2022 representing a change of -12.43%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.
Accounts Payables: The absolute value of Accounts Payables decreased to 16 million in 2023 from 48 million in 2022 representing a change of -65.96%. This indicates that the company has reduced its outstanding obligations to its suppliers.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0001551306 | |||
| operating cash flow | 44515000 | 56694000 | -21.48 |
| free cash flow | 42721000 | 55828000 | -23.48 |
| capital expenditure | -1794000 | -866000 | -107.16 |
| depreciation and amortization | 837000 | 754000 | 11.01 |
| deferred income tax | 4829000 | 2645000 | 82.57 |
| stock based compensation | 33183000 | 33036000 | 0.44 |
| accounts receivables | 9917000 | -1378000 | 819.67 |
| accounts payables | -21324000 | 21606000 | -198.69 |
| inventory | 0 | 0 | NaN |
| acquisitions net | 0 | -5304000 | 100.00 |
| investments in property plant and equipment | -1794000 | -866000 | -107.16 |
| net cash used for investing activites | 15362000 | 86096000 | -82.16 |
| debt repayment | 0 | 0 | NaN |
| common stock issued | 0 | 0 | NaN |
| common stock repurchased | -61453000 | -159959000 | 61.58 |
| dividends paid | 0 | 0 | NaN |
| net cash used provided by financing activities | -63353000 | -162789000 | 61.08 |
| net change in cash | -3480000 | -19999000 | 82.60 |
| cash at end of period | 91480000 | 94960000 | -3.66 |
| cash at beginning of period | 94960000 | 114959000 | -17.40 |
Net Change in Cash: Net Change in Cash increased to -3 million in 2024Q3 from -20 million in 2024Q2 representing a change of 82.6%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.
Capital Expenditure: Capital Expenditure decreased to -2 million in 2024Q3 from -1 million in 2024Q2 representing a change of -107.16%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.
Accounts Payables: The absolute value of Accounts Payables decreased to 21 million in 2024Q3 from 22 million in 2024Q2 representing a change of -198.69%. This indicates that the company has reduced its outstanding obligations to its suppliers.
Operating Cash Flow: Operating Cash Flow decreased to 45 million in 2024Q3 from 57 million in 2024Q2 representing a change of -21.48%. This indicates that the company generated less cash from its core business operations.
Free Cash Flow: Free Cash Flow decreased to 43 million in 2024Q3 from 56 million in 2024Q2 representing a change of -23.48%. This indicates a decrease in cash generated after accounting for capital expenditures.
Deferred Income Tax: Deferred Income Tax increased to 5 million in 2024Q3 from 3 million in 2024Q2 representing a change of 82.57%. This indicates that the company's tax liability for future periods has increased.
Stock-Based Compensation: Stock-Based Compensation increased to 33 million in 2024Q3 from 33 million in 2024Q2 representing a change of 0.44%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.
Accounts Receivables: Accounts Receivables increased to 10 in 2024Q3 from -1 million in 2024Q2 representing a change of 819.67%. This suggests that the company is less capable of collecting payments from its customers.
We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.
Note: The years mentioned below are fiscal years in accounting.
Q3 2024 Earnings call transcript
EPS represents the portion of a company's profit allocated to each outstanding share of common stock. A higher EPS is generally favorable, indicating stronger profitability on a per-share basis.
Positive EPS: A positive EPS signifies that a company is profitable, it is generally viewed positively, supporting stock value and investor confidence.
Negative EPS: Indicates that a company is operating at a loss, which could lead to negative sentiment, potential stock depreciation, and concerns about the company's financial health.
The Next Earning Date represents when the company plans to release its next set of financial results.
An upward trend in EPS suggests consistent growth in earnings, often leading to increased investor confidence. A downward trend may indicate a decline in earnings, potentially decreasing investor confidence and stock value. Fluctuating EPS suggests unpredictable financial performance, warranting cautious investor analysis.
Earnings surprise occurs when a company's actual earnings differ from analysts' expectations. A positive earnings surprise typically reflects better-than-expected performance, potentially leading to stock appreciation. Conversely, a negative earnings surprise can result in stock depreciation. An earnings surprise of zero means the earnings met expectations, which typically has a neutral impact on stock price.
Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.
| 2023-12-31 | 2022-12-31 | Y/Y change % | |
|---|---|---|---|
| FY | |||
| calendar year | 2023 | 2022 | NaN |
| revenue per share | 11.46 | 8.54 | 34.22 |
| net income per share | 0.65 | 0.33 | 98.27 |
| operating cash flow per share | 1.99 | 0.87 | 127.87 |
| free cash flow per share | 1.95 | 0.84 | 132.86 |
| cash per share | 3.91 | 2.05 | 90.20 |
| book value per share | 5.82 | 4.09 | 42.44 |
| tangible book value per share | 5.7 | 3.96 | 43.96 |
| shareholders equity per share | 5.82 | 4.09 | 42.44 |
| interest debt per share | 0.2 | 0.09 | 120.63 |
| market cap | 3532887286.5 | 2871876368.2 | 23.02 |
| enterprise value | 3454981286.5 | 2759511368.2 | 25.20 |
| pe ratio | 56.95 | 94.6 | -39.80 |
| price to sales ratio | 3.25 | 3.65 | -11.08 |
| pocfratio | 18.71 | 35.72 | -47.62 |
| pfcf ratio | 19.08 | 37.22 | -48.74 |
| pb ratio | 6.38 | 7.62 | -16.21 |
| ptb ratio | 6.38 | 7.62 | -16.21 |
| ev to sales | 3.17 | 3.51 | -9.49 |
| enterprise value over ebitda | 53.59 | 110.64 | -51.56 |
| ev to operating cash flow | 18.3 | 34.32 | -46.69 |
| ev to free cash flow | 18.66 | 35.77 | -47.83 |
| earnings yield | 0.02 | 0.01 | 66.12 |
| free cash flow yield | 0.05 | 0.03 | 95.10 |
| debt to equity | 0.04 | 0.02 | 71.24 |
| debt to assets | 0.03 | 0.01 | 80.41 |
| net debt to ebitda | -1.21 | -4.51 | 73.17 |
| current ratio | 3.44 | 2.72 | 26.64 |
| interest coverage | 0 | 28.67 | -100.00 |
| income quality | 3.04 | 2.65 | 14.93 |
| dividend yield | 0 | 0 | NaN |
| payout ratio | 0 | 0 | NaN |
| sales general and administrative to revenue | 0.11 | 0.12 | -13.89 |
| research and ddevelopement to revenue | 0 | 0 | NaN |
| intangibles to total assets | 0.02 | 0.02 | -28.83 |
| capex to operating cash flow | 0.02 | 0.04 | -52.13 |
| capex to revenue | 0.0 | 0.0 | -18.72 |
| capex to depreciation | 1.6 | 2.02 | -21.08 |
| stock based compensation to revenue | 0.11 | 0.13 | -12.03 |
| graham number | 9.25 | 5.5 | 68.06 |
| roic | 0.1 | 0.08 | 26.41 |
| return on tangible assets | 0.08 | 0.06 | 45.70 |
| graham net net | 3.68 | 2.21 | 66.68 |
| working capital | 454457000 | 274320000 | 65.67 |
| tangible asset value | 541549000 | 364989000 | 48.37 |
| net current asset value | 437216000 | 267838000 | 63.24 |
| invested capital | 494155000 | 301573000 | 63.86 |
| average receivables | 240968000 | 187312000 | 28.65 |
| average payables | 117356500 | 85343000 | 37.51 |
| average inventory | 0 | 0.5 | -100.00 |
| days sales outstanding | 81.1 | 111.35 | -27.17 |
| days payables outstanding | 53.87 | 64.38 | -16.32 |
| days of inventory on hand | 0 | 0 | NaN |
| receivables turnover | 4.5 | 3.28 | 37.31 |
| payables turnover | 6.78 | 5.67 | 19.51 |
| inventory turnover | 0 | 0 | NaN |
| roe | 0.11 | 0.08 | 39.19 |
| capex per share | 0.04 | 0.04 | 9.09 |
ROE:
PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 56.95 on 2023-12-31 from 94.60 on 2022-12-31, representing a change of -39.80%. Indicating a decrease in the relative valuation of the company's stock.
Current Ratio: Current Ratio increased to 3.44 on 2023-12-31 from 2.72 on 2022-12-31, representing a change of 26.64%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.
Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.04 on 2023-12-31 from 0.02 on 2022-12-31, representing a change of 71.24%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.
| 2024-09-30 Q3 | 2024-06-30 Q2 | Q/Q change % | |
|---|---|---|---|
| PGNY | |||
| calendar year | 2024 | 2024 | NaN |
| revenue per share | 3.18 | 3.24 | -1.76 |
| net income per share | 0.12 | 0.18 | -34.12 |
| operating cash flow per share | 0.49 | 0.6 | -18.17 |
| free cash flow per share | 0.47 | 0.59 | -20.25 |
| cash per share | 2.62 | 2.79 | -6.30 |
| book value per share | 4.83 | 4.86 | -0.65 |
| tangible book value per share | 4.64 | 4.68 | -0.88 |
| shareholders equity per share | 4.83 | 4.86 | -0.65 |
| interest debt per share | 0.18 | 0.21 | -12.78 |
| market cap | 1509534233.0 | 2663985447.42 | -43.34 |
| enterprise value | 1434679233.0 | 2588891447.42 | -44.58 |
| pe ratio | 36.21 | 40.4 | -10.36 |
| price to sales ratio | 5.27 | 8.76 | -39.88 |
| pocfratio | 33.91 | 46.99 | -27.83 |
| pfcf ratio | 35.33 | 47.72 | -25.95 |
| pb ratio | 3.47 | 5.84 | -40.56 |
| ptb ratio | 3.47 | 5.84 | -40.56 |
| ev to sales | 5.01 | 8.51 | -41.21 |
| enterprise value over ebitda | 115.16 | 120.74 | -4.62 |
| ev to operating cash flow | 32.23 | 45.66 | -29.42 |
| ev to free cash flow | 33.58 | 46.37 | -27.58 |
| earnings yield | 0.01 | 0.01 | 11.56 |
| free cash flow yield | 0.03 | 0.02 | 35.04 |
| debt to equity | 0.04 | 0.04 | -12.21 |
| debt to assets | 0.03 | 0.03 | -11.41 |
| net debt to ebitda | -6.01 | -3.5 | -71.56 |
| current ratio | 2.62 | 2.58 | 1.44 |
| interest coverage | 0 | 0 | NaN |
| income quality | 4.27 | 3.44 | 24.21 |
| dividend yield | 0 | 0 | NaN |
| payout ratio | 0 | 0 | NaN |
| sales general and administrative to revenue | 0.11 | 0.1 | 3.22 |
| research and ddevelopement to revenue | 0 | 0 | NaN |
| intangibles to total assets | 0.03 | 0.02 | 6.84 |
| capex to operating cash flow | 0.04 | 0.02 | 163.84 |
| capex to revenue | 0.01 | 0.0 | 119.78 |
| capex to depreciation | 2.14 | 1.15 | 86.62 |
| stock based compensation to revenue | 0.12 | 0.11 | 6.56 |
| graham number | 3.55 | 4.38 | -19.10 |
| roic | 0.02 | 0.03 | -44.31 |
| return on tangible assets | 0.02 | 0.02 | -32.97 |
| graham net net | 2.46 | 2.56 | -4.00 |
| working capital | 337831000 | 356868000 | -5.33 |
| tangible asset value | 417632000 | 439108000 | -4.89 |
| net current asset value | 321206000 | 339804000 | -5.47 |
| invested capital | 384442000 | 402396000 | -4.46 |
| average receivables | 287260000 | 295502500 | -2.79 |
| average payables | 141105000 | 140958999.5 | 0.10 |
| average inventory | 0 | 0.5 | -100.00 |
| days sales outstanding | 88.15 | 86.95 | 1.37 |
| days payables outstanding | 51.64 | 57.92 | -10.84 |
| days of inventory on hand | 0 | 0 | NaN |
| receivables turnover | 1.02 | 1.04 | -1.35 |
| payables turnover | 1.74 | 1.55 | 12.16 |
| inventory turnover | 0 | 0 | NaN |
| roe | 0.02 | 0.04 | -33.69 |
| capex per share | 0.02 | 0.01 | 115.90 |
ROE: Return on Equity (ROE) decreased to 0.02 on 2024-09-30 Q3 from 0.04 on 2024-06-30 Q2, representing a change of -33.69%. Suggesting that the company has not been generating high returns for its shareholders.
PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 36.21 on 2024-09-30 Q3 from 40.40 on 2024-06-30 Q2, representing a change of -10.36%. Indicating a decrease in the relative valuation of the company's stock.
Current Ratio: Current Ratio increased to 2.62 on 2024-09-30 Q3 from 2.58 on 2024-06-30 Q2, representing a change of 1.44%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.
Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.04 on 2024-09-30 Q3 from 0.04 on 2024-06-30 Q2, representing a change of -12.21%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.
Positive Sentiment: Discounted Cash Flow value is 64.45 which is higher than current price 23.32, indicates the company may be undervalued.
| Market Capitalization | Enterprise Value | |
|---|---|---|
| Definition | The total market value of a company's outstanding shares | The total market value of a company, including its debt and other liabilities |
| Calculation | Current share price * Total number of outstanding shares | Market capitalization + Total debt - Cash and cash equivalents |
| Focus | Equity component of a company's value | Total economic value of a company |
| Usefulness | Assesses a company's size and growth potential based on investor sentiment | Provides a more comprehensive valuation that considers both equity and debt |
Analyzing dividends is a crucial aspect of investment evaluation, offering valuable insights into a company's financial health and its commitment to shareholder returns. Dividends represent a portion of a company's profits distributed to its shareholders, providing a steady income stream. We help you analyze dividends based on the indicators mentioned below:
• Investors often assess the average dividend amount, observing trends over time to gauge the company's stability and growth potential. A positive trend in average dividends indicates a consistent and potentially lucrative investment. Additionally, evaluating the trend of dividend increases provides insight into the company's financial strength and management's confidence in future earnings.
• Consistency in paying dividends is a reassuring sign, reflecting a company's reliability and commitment to shareholder value. For investors, dividends not only offer income but also contribute to the overall total return on investment.
• Companies with a history of regular and increasing dividends can attract income-focused investors seeking stable returns, making dividends a critical factor in building a well-rounded investment portfolio.
Interested in the overall sentiment for a particular period? Check out our news sentiment analysis tool.
Sentiment: Positive
Publish Date: 2025-01-29 13:11:28
Progyny (PGNY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Sentiment: Positive
Publish Date: 2025-01-28 08:44:00
Provides expecting parents with a concierge-level service model that delivers expert guidance, navigation and support for parental leave planning Provides expecting parents with a concierge-level service model that delivers expert guidance, navigation and support for parental leave planning
Sentiment: Positive
Publish Date: 2025-01-16 09:00:00
NEW YORK, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building and women's health benefits solution, today announced the appointment of 30-year healthcare industry veteran Debra Morris to its board of directors, effective January 16, 2025.
Sentiment: Positive
Publish Date: 2025-01-13 08:00:00
BLOOMFIELD, Conn. , Jan. 13, 2025 /PRNewswire/ -- Cigna Healthcare, the health benefits division of The Cigna Group (NYSE: CI), today announced a new offering in collaboration with Progyny, Inc (Nasdaq: PGNY) that makes best-in-class fertility and family-building services accessible and equitable for more employers.
Sentiment: Positive
Publish Date: 2025-01-07 21:20:00
NEW YORK , Jan. 7, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Progyny, Inc. (NASDAQ: PGNY) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing.
Sentiment: Positive
Publish Date: 2024-12-30 20:17:28
Progyny shares have plummeted nearly 80% from 2021's peak, but management optimism and insider buying in December signal a potential turnaround during 2025. PGNY's valuation is deeply discounted, with strong fundamentals: $235M in cash, no debt, and 9.64% in trailing free cash flow yield. The stock's rare accumulation/momentum pattern since September and potential short squeeze kicker make it an attractive Buy.
Sentiment: Positive
Publish Date: 2024-12-18 20:33:00
SAN DIEGO , Dec. 18, 2024 /PRNewswire/ -- Shareholder rights law firm Robbins LLP is investigating Progyny, Inc. (NASDAQ: PGNY) to determine whether certain Progyny officers and directors violated securities laws and breached fiduciary duties to shareholders. Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States.
Sentiment: Negative
Publish Date: 2024-12-18 10:42:00
SAN DIEGO, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP is investigating whether Progyny, Inc. (NASDAQ: PGNY) or others violated securities laws by misrepresenting or failing to timely disclose material adverse to investors. The investigation focuses on investors' losses and whether they may be recovered under federal securities laws.
Sentiment: Positive
Publish Date: 2024-12-11 22:38:00
SAN DIEGO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP is investigating Progyny, Inc. (NASDAQ: PGNY) to determine whether certain Progyny officers and directors violated securities laws and breached fiduciary duties to shareholders. Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States.
Sentiment: Negative
Publish Date: 2024-12-03 08:45:00
SAN DIEGO, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP is investigating whether Progyny, Inc. (NASDAQ: PGNY) or others violated securities laws by misrepresenting or failing to timely disclose material adverse to investors. The investigation focuses on investors' losses and whether they may be recovered under federal securities laws.
Sentiment: Negative
Publish Date: 2024-11-26 07:54:16
I recommend downgrading Progyny from buy to hold due to a loss of confidence in its growth outlook and increased uncertainty. PGNY's Q3 2024 results were disappointing, with revenue and margins falling short of expectations, leading to lowered FY24 guidance. Declines in ART cycles and a weaker 2024 sales season raise concerns about underlying demand, despite potential upsides from upselling adjacent solutions.
Sentiment: Negative
Publish Date: 2024-11-18 11:25:00
SAN DIEGO, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Progyny, Inc. (NASDAQ: PGNY) or others violated securities laws by misrepresenting or failing to timely disclose material adverse to investors. The investigation focuses on investors' losses and whether they may be recovered under federal securities laws.
Sentiment: Negative
Publish Date: 2024-11-17 23:47:22
I initially rated Progyny a "Buy" in late 2022, but 2024 has been disastrous, with a 60% stock drop and loss of Amazon as a client. Q3 2024 financials show minimal revenue growth, declining margins, and lower earnings per share, despite a strong balance sheet. Given management's struggles and increased competition, I no longer believe Progyny has a competitive advantage and have sold my shares.
Sentiment: Positive
Publish Date: 2024-11-14 09:00:00
NEW YORK, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced that Pete Anevski, Progyny's Chief Executive Officer, and Mark Livingston, Chief Financial Officer, will participate in a fireside chat at the Jefferies London Healthcare Conference on Tuesday, November 19, 2024, at 8:00 a.m. GMT (3:00 a.m. EST).
Sentiment: Neutral
Publish Date: 2024-11-13 16:40:05
Why Progyny Stock Crashed Today
Sentiment: Negative
Publish Date: 2024-11-13 09:45:41
Progyny, Inc. PGNY reported worse-than-expected third-quarter sales results and issued FY24 revenue guidance below estimates.
Sentiment: Positive
Publish Date: 2024-11-12 20:15:02
Progyny, Inc (NASDAQ:PGNY ) Q3 2024 Earnings Conference Call November 12, 2024 4:45 PM ET Company Participants James Hart - Investor Relations Peter Anevski - CEO Michael Sturmer - President Mark Livingston - CFO Conference Call Participants Anne Samuel - JPMorgan Allen Lutz - Bank of America Sarah James - Cantor Fitzgerald Michael Cherny - Leering Partners Glen Santangelo - Jefferies Jailendra Singh - Truist Securities Stephanie Davis - Barclays Scott Schoenhaus - KeyBanc Richard Close - Canaccord Genuity David Larsen - BTIG Operator Good day, and welcome to the Progyny, Inc. Third Quarter Earnings Conference Call. At this time all participants have been placed on listen-only mode.
Sentiment: Positive
Publish Date: 2024-11-12 18:41:49
Progyny (PGNY) came out with quarterly earnings of $0.40 per share, beating the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.16 per share a year ago.
Sentiment: Positive
Publish Date: 2024-11-12 16:02:00
Sales Season Yields Over 80 New Clients, 1.1 Million New Covered LivesSelected by a Leading National Health Plan and a Regional Health Plan as Their Preferred Partner1.5 Million Lives Adopt Newest Services in Maternity and/or Menopause Programs in 2025
Sentiment: Positive
Publish Date: 2024-11-08 09:20:00
SAN FRANCISCO, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Fertility benefits provider Progyny, Inc. (NASDAQ: PGNY) is under intense scrutiny following the unexpected announcement of a major client's departure.
* The sentiment analysis presented is generated through an algorithm and may be subject to inaccuracies. Users are advised to corroborate key information and employ further analytical methods prior to making critical decisions.
Get instant AI-powered professional insights:
💡Generate AI Technical Analysis ReportUnderstand the chart below:
Interpret Technical Indicators
| Indicator | Bullish | Bearish |
|---|---|---|
| Price and EMA ⓘ | Price crosses above EMA | Price crosses below EMA |
| Short-Term vs Long-Term EMA ⓘ | Short EMA crosses above Long EMA | Short EMA crosses below Long EMA |
| Volume ⓘ | Increasing volume during price uptrend | Increasing volume during price downtrend |
| MACD ⓘ | MACD crosses above Signal Line | MACD crosses below Signal Line |
| RSI ⓘ | RSI is below 30 (oversold) and starts to rise above 30 | RSI is above 70 (overbought) and starts to decline below 70 |
| Candlestick Patterns ⓘ | Bullish candlestick patterns | Bearish candlestick patterns |
Copyright © 2024 Sirius Investors
All rights reserved
